After numerous requests, the Registrar, Own Identity, Inc., has not confirmed to the Forum that the domain name is registered with Own Identity, Inc. or Respondent is the current registrant of the name.� Registrar�s non-compliance has been reported to ICANN as of December 1, 2015.� The FORUM�s standing instructions are to proceed with this dispute. After numerous requests, the Registrar, Web4Africa Inc., has not confirmed to the Forum that the and domain names are registered with Web4Africa Inc. or Respondent is the current registrant of the names.� Registrar�s non-compliance has been reported to ICANN as of December 1, 2015.� The FORUM�s standing instructions are to proceed with this dispute.

Manufacturers And Registration

On December 11, 2015, the Forum served the Complaint and all Annexes, including a Written Notice of the Complaint, setting a deadline of December 31, 2015 by which Respondent could file a Response to the Complaint, via e-mail to all entities and persons listed on Respondent�s registration as technical, administrative, and billing contacts, and to postmaster@cialis-pharmacie.net, postmaster@comprarcialisgenericoespana10mg.net, postmaster@achat-cialis-pascher.net, postmaster@acheter-cialis-pascher.net, postmaster@cialis-achat.net, postmaster@commandercialisenligne.net, postmaster@comprar-cialis-es.net, postmaster@comprarcialisgenericobarato.net, postmaster@comprargenericocialisespana.net, postmaster@prix-cialis-generique.net, postmaster@prezzocialisgenerico.net, postmaster@acquistocialisgenerico20mg.net, postmaster@prix-cialis-france.net, postmaster@acquistare-cialis-generico.net, postmaster@kaufencialisgenerikade.net, postmaster@achetercialisgeneriquesansordonnance.net, postmaster@comprarcialisgenericosinreceta.com, postmaster@achatcialisgeneriquepascher.com, postmaster@acquistarecialisgenericoitalia.net, postmaster@buycheapgenericcialisonlineusa.com, postmaster@cialis-generika-bestellen.com, postmaster@cialis-generiques-france.com, postmaster@cialis4u.com, postmaster@cialisfrance.com, postmaster@cialisgenerique-en-ligne.com, postmaster@potenzmittel-cialis.com, postmaster@viagracialisde.com, postmaster@wo-cialis-bestellen.com, postmaster@achatcialisgenerique10mg.net, postmaster@achetercialis40mg.net, postmaster@acquistarecialisgenerico20mg.net, postmaster@cialis-compresse.net, postmaster@cialis-espana2013.net, postmaster@cialis-farmacia.net, postmaster@cialisacquistaregenerico.net, postmaster@cialisacquistogenerico.net, postmaster@comprarcialisgenerico10mg.net, postmaster@comprarcialisgenerico20mg.net, postmaster@comprarcialisgenericoes1.net, postmaster@comprarcialisgenericoes10mg.net, postmaster@comprarcialisgenericomg.net, postmaster@comprarcialisgenericosinreceta.net, postmaster@prixcialisgenerique1.net, postmaster@cialis-pillen.net, postmaster@cialisachetergenerique.net, postmaster@comprarcialisgenerico40mg.net, postmaster@comprarcialissinreceta.net, postmaster@kaufen-cialis-generika.net, postmaster@kaufencialisgenerika40mg.net, postmaster@kaufencialisgenerikamg.net, postmaster@kaufencialisgenerikaonline.net, postmaster@preise-cialis-generika.net, postmaster@acquistare-cialis-senzaricetta.net, postmaster@acquistarecialisgenerico1.net, postmaster@acquistocialisgenerico10mg.net, postmaster@acquistocialisgenericomg.net, postmaster@cheapcialisgeneric20mg.net, postmaster@cialis-generique-france.net, postmaster@cialis-pharmaciefr.net, postmaster@cialisenlignefr.net, postmaster@cialisgeneriquefr.net, postmaster@comprar-cialis-farmacia.net, postmaster@comprarecialisgenerico40mg.net, postmaster@genericcialisnoprescription.net, postmaster@pharmacie-cialis.net, postmaster@prezzocialisgenerico10mg.net, postmaster@prezzocialisitalia.net, postmaster@achatcialisgenerique20mg.net, postmaster@comprarcialisgenerico40mg.com, postmaster@prezzocialisgenericoonline.com, and postmaster@cialis-pastilla.net.� Also on December 11, 2015, the Written Notice of the Complaint, notifying Respondent of the e-mail addresses served and the deadline for a Response, was transmitted to Respondent via post and fax, to all entities and persons listed on Respondent�s registration as technical, administrative and billing contacts.

Product Dosage Quantity + Bonus Price
Cialis Original20mg48 + 4 Pills224.69€ 213.99€
Cialis Original20mg4 Pills41.99€ 39.99€
Cialis Professional20mg270 + 6 Pills623.07€ 593.40€
Cialis Original20mg22 + 2 Pills129.20€ 123.05€
Cialis Professional40mg180 + 4 Pills618.23€ 588.79€
Cialis Original20mg76 + 4 Pills319.19€ 303.99€
Cialis Super Active20mg120 + 16 Pills382.15€ 363.95€
Cialis Super Active20mg180 + 20 Pills521.59€ 496.75€
Cialis Generic20mg20 Pills54.72€ 52.11€
Cialis Generic20mg30 + 4 Pills68.05€ 64.81€
Cialis Original20mg120 + 8 Pills497.29€ 473.61€
Cialis Generic5mg30 + 4 Pills53.56€ 51.01€
Cialis Generic5mg270 + 10 Pills205.81€ 196.01€

Having received no response from Respondent, the Forum transmitted to the parties a Notification of Respondent Default. On January 8, 2016, pursuant to Complainant's request to have the dispute decided by a single-member Panel, the Forum appointed Houston Putnam Lowry, Chartered Arbitrator, as Panelist. Having reviewed the communications records, the Administrative Panel (the "Panel") finds that the Forum has discharged its responsibility under Paragraph 2(a) of the Rules for Uniform Domain Name Dispute Resolution Policy (the "Rules") "to employ reasonably available means calculated to achieve actual notice to Respondent" through submission of Electronic and Written Notices, as defined in Rule 1 and Rule 2. Therefore, cialis pricing 20mg the Panel may issue its decision based on the documents submitted and in accordance with the ICANN Policy, ICANN Rules, the Forum's Supplemental Rules and any rules and principles of law that the Panel deems applicable, without the benefit of any response from Respondent.

Prescription Refills

Pricing Information

Common Alternatives

Complainant requests that the domain names be transferred from Respondent to Complainant. ]��������� The Domain Names are confusingly similar to a trademark in which the Complainant has rights.

Patient Forms

After numerous requests, the Registrar, Own Identity, Inc., has not confirmed to the Forum that the domain name is registered with Own Identity, Inc. or Respondent is the current registrant of the name.� Registrar�s non-compliance has been reported to ICANN as of December 1, 2015.� The FORUM�s standing instructions are to proceed with this dispute. After numerous requests, the Registrar, Web4Africa Inc., has not confirmed to the Forum that the and domain names are registered with Web4Africa Inc. or Respondent is the current registrant of the names.� Registrar�s non-compliance has been reported to ICANN as of December 1, 2015.� The FORUM�s standing instructions are to proceed with this dispute. On December 11, 2015, the Forum served the Complaint and all Annexes, including a Written Notice of the Complaint, setting a deadline of December 31, 2015 by which Respondent could file a Response to the Complaint, via e-mail to all entities and persons listed on Respondent�s registration as technical, administrative, and billing contacts, and to postmaster@cialis-pharmacie.net, postmaster@comprarcialisgenericoespana10mg.net, postmaster@achat-cialis-pascher.net, postmaster@acheter-cialis-pascher.net, postmaster@cialis-achat.net, postmaster@commandercialisenligne.net, postmaster@comprar-cialis-es.net, postmaster@comprarcialisgenericobarato.net, postmaster@comprargenericocialisespana.net, postmaster@prix-cialis-generique.net, postmaster@prezzocialisgenerico.net, postmaster@acquistocialisgenerico20mg.net, postmaster@prix-cialis-france.net, postmaster@acquistare-cialis-generico.net, postmaster@kaufencialisgenerikade.net, postmaster@achetercialisgeneriquesansordonnance.net, postmaster@comprarcialisgenericosinreceta.com, postmaster@achatcialisgeneriquepascher.com, postmaster@acquistarecialisgenericoitalia.net, postmaster@buycheapgenericcialisonlineusa.com, postmaster@cialis-generika-bestellen.com, postmaster@cialis-generiques-france.com, postmaster@cialis4u.com, postmaster@cialisfrance.com, postmaster@cialisgenerique-en-ligne.com, postmaster@potenzmittel-cialis.com, postmaster@viagracialisde.com, postmaster@wo-cialis-bestellen.com, postmaster@achatcialisgenerique10mg.net, postmaster@achetercialis40mg.net, postmaster@acquistarecialisgenerico20mg.net, postmaster@cialis-compresse.net, postmaster@cialis-espana2013.net, postmaster@cialis-farmacia.net, postmaster@cialisacquistaregenerico.net, postmaster@cialisacquistogenerico.net, postmaster@comprarcialisgenerico10mg.net, postmaster@comprarcialisgenerico20mg.net, postmaster@comprarcialisgenericoes1.net, postmaster@comprarcialisgenericoes10mg.net, postmaster@comprarcialisgenericomg.net, postmaster@comprarcialisgenericosinreceta.net, postmaster@prixcialisgenerique1.net, postmaster@cialis-pillen.net, postmaster@cialisachetergenerique.net, postmaster@comprarcialisgenerico40mg.net, postmaster@comprarcialissinreceta.net, postmaster@kaufen-cialis-generika.net, postmaster@kaufencialisgenerika40mg.net, postmaster@kaufencialisgenerikamg.net, postmaster@kaufencialisgenerikaonline.net, postmaster@preise-cialis-generika.net, postmaster@acquistare-cialis-senzaricetta.net, postmaster@acquistarecialisgenerico1.net, postmaster@acquistocialisgenerico10mg.net, postmaster@acquistocialisgenericomg.net, postmaster@cheapcialisgeneric20mg.net, postmaster@cialis-generique-france.net, postmaster@cialis-pharmaciefr.net, postmaster@cialisenlignefr.net, postmaster@cialisgeneriquefr.net, postmaster@comprar-cialis-farmacia.net, postmaster@comprarecialisgenerico40mg.net, postmaster@genericcialisnoprescription.net, postmaster@pharmacie-cialis.net, postmaster@prezzocialisgenerico10mg.net, postmaster@prezzocialisitalia.net, postmaster@achatcialisgenerique20mg.net, postmaster@comprarcialisgenerico40mg.com, postmaster@prezzocialisgenericoonline.com, and postmaster@cialis-pastilla.net.� Also on December 11, 2015, the Written Notice of the Complaint, notifying Respondent of the e-mail addresses served and the deadline for a Response, was transmitted to Respondent via post and fax, to all entities and persons listed on Respondent�s registration as technical, administrative and billing contacts.

Payment Methods

Having received no response from Respondent, the Forum transmitted to the parties a Notification of Respondent Default. On January 8, 2016, pursuant to Complainant's request to have the dispute decided by a single-member Panel, the Forum appointed Houston Putnam Lowry, Chartered Arbitrator, as Panelist. Having reviewed the communications records, the Administrative Panel (the "Panel") finds that the Forum has discharged its responsibility under Paragraph 2(a) of the Rules for Uniform Domain Name Dispute Resolution Policy (the "Rules") "to employ reasonably available means calculated to achieve actual notice to Respondent" through submission of Electronic and Written Notices, as defined in Rule 1 and Rule 2. Therefore, cialis pricing 20mg the Panel may issue its decision based on the documents submitted and in accordance with the ICANN Policy, ICANN Rules, the Forum's Supplemental Rules and any rules and principles of law that the Panel deems applicable, without the benefit of any response from Respondent. Complainant requests that the domain names be transferred from Respondent to Complainant.

Doctor Preferences

]��������� The Domain Names are confusingly similar to a trademark in which the Complainant has rights. �� (1)� Complainant's use and registration of the CIALIS trademark pre-dates Respondents� registration of the Domain Names. Complainant owns numerous trademark registrations throughout the world for its CIALIS mark and Complainant's rights in the CIALIS mark date back to as early as 1999. In 2004, approximately $39 million was spent to market and sell CIALIS brand product worldwide, U.S. sales of the CIALIS brand product totaled more than $206 million, and worldwide sales of CIALIS brand product were in excess of $550 million.� Over the years, sales of Complainant�s CIALIS brand product have steadily and significantly increased.� In 2013, worldwide sales of CIALIS brand product increased to $2.159 billion. �� (1)� Complainant's use and registration of the CIALIS trademark pre-dates Respondents� registration of the Domain Names.

Year Number of Prescriptions Growth Rate (%) Key Markets
2022 10 million 5% USA, Europe
2023 11.2 million 12% North America, Asia
2024 12.5 million 11% Worldwide

Complainant owns numerous trademark registrations throughout the world for its CIALIS mark and Complainant's rights in the CIALIS mark date back to as early as 1999. In 2004, approximately $39 million was spent to market and sell CIALIS brand product worldwide, U.S. sales of the CIALIS brand product totaled more than $206 million, and worldwide sales of CIALIS brand product were in excess of $550 million.� Over the years, sales of Complainant�s CIALIS brand product have steadily and significantly increased.� In 2013, worldwide sales of CIALIS brand product increased to $2.159 billion. Most recently, for the full year 2014, worldwide sales of CIALIS brand product increased 6% to $2.291 billion, with sales in the United States at $1.040 billion and sales outside of the United States at $1.251 billion.

Country Prescription Requirement Sale Restrictions Age Limit
USA Prescription mandatory Online and pharmacy 18+
Germany Prescription required In pharmacies only 18+
Australia Prescription needed Only in pharmacies 18+

For these reasons, Complainant believes that it is reasonable to infer that the CIALIS trademark is well-known throughout the world. Because the Respondents registered the Domain Names between 2012 and 2015, Complainant's rights in the CIALIS trademark predate Respondents� registration dates, and Complainant has both senior and exclusive rights in the CIALIS mark.

Step Action Notes
1 Take with water On an empty or full stomach
2 Avoid high-fat meals before May delay absorption
3 Do not exceed prescribed dose Risk of side effects
4 Engage in sexual activity after 1 hour For best results

�Complainant also has an Internet presence, primarily through the website accessed by the domain name , that it uses to advertise and provide information regarding its pharmaceutical product.�� The domain name was registered by Complainant's predecessor-in-interest on August 10, 1999.� Complainant has used this domain name to identify a website since at least as early as June, 2001.

Recent Clinical Studies on Cialis

Complainant submits and prior Panels cialis over the counter uk have agreed that the CIALIS mark is an invented word that has a high degree of individuality, inherent distinctiveness and no common colloquial use.� See Lilly ICOS LLC v. Clarkepharma Co., D2007-0447 (WIPO, May 25, 2007).� An invented word which has acquired a high degree of distinctiveness is deemed to be a highly distinctive mark.

Are There Alternative Names for the Brand and Generic Cialis?

See Telstra Corporation Limited v. Telsra/Telecomunicaciones Serafin Rodriguez y Asociados, D2003-0247 (WIPO, July 21, 2003) (determined that since the mark TELSTRA is an invented word and given its nature, widespread advertisement and exposure to consumers worldwide, the mark is highly distinctive).� A domain name which differs very slightly from a trademark has a greater tendency to be confusingly similar where that trademark is highly distinctive.� See Credit Suisse Group v. VPDD UBGM ltd, D2007-0867 (WIPO, September 10, 2007).� �� (3)��� The Domain Names are confusingly similar to the CIALIS mark.

  • Cialis can help men regain sexual function.
  • It is a long-acting ED medication.
  • Side effects are usually mild and temporary.
  • Serious reactions require immediate medical attention.
  • Discuss all health conditions with your doctor.
  • Follow dosing guidelines strictly.
  • Cialis is available in various formulations.
  • Check if your pharmacy offers consultations.
  • Use Cialis as part of a comprehensive treatment plan.
  • Avoid using Cialis with certain heart medications.
  • Inform your healthcare provider of all supplements used.
  • Use caution if you experience vision or hearing changes.

The Domain Names are confusing similar to Complainant�s CIALIS mark.� The addition of generic or descriptive words such as "buy," "cheap," and "generic," to Complainant's highly distinctive CIALIS trademark does not prevent a finding of confusing similarity.� Prior Forum Panels have noted that, "the mere addition of a generic or descriptive abbreviation to a registered mark does not negate the confusing similarity of respondent's domain name. "� Lilly ICOS LLC v.

  • Purchase Cialis only from licensed pharmacies.
  • Verify the medication’s packaging for authenticity.
  • Beware of counterfeit Cialis sold online.
  • Store Cialis in a cool, dry place.
  • Keep Cialis out of reach of children.
  • Do not use Cialis if you have heart issues.
  • Discuss your medical history before use.
  • Report any adverse reactions to your doctor.
  • Cialis is contraindicated with certain medications.
  • Do not exceed the prescribed dosage.
  • Be aware of possible side effects like dizziness.
  • Consult your doctor for proper usage guidance.

Joe Pestrak, FA 0504000464558 (NAF, May 31, 2005).� As a result, the addition of generic or descriptive words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark.� See Lilly ICOS LLC v. Andrew Riegel, FA0609000788279 (NAF, October 18, 2006) (finding the addition of the generic term "buy" to Complainant's CIALIS mark did not overcome the confusing similarity between the disputed domain name and the CIALIS mark); Lilly ICOS LLC v.

Medication details

Subjective Insights

Side Effects

Jay Kim, D2004-0891 (WIPO, January 28, 2005) (finding the addition of the generic word "generic" and the generic letter "a" to Complainant's CIALIS mark did not prevent the domain name from being confusingly similar to the CIALIS mark); and Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (determining that the addition of the words "drug", "online", "buying" and "guide" to Complainant's registered CIALIS trademark did not eliminate the confusing similarity between the CIALIS mark and the domain name because the additional words did not distinguish the owner of the disputed name from Complainant).� In the present case, Respondents have merely added generic and/or descriptive words and phrases to the CIALIS mark in the Domain Names.� Respondents� addition of these words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark.

Basic Cialis Information

Most recently, for the full year 2014, worldwide sales of CIALIS brand product increased 6% to $2.291 billion, with sales in the United States at $1.040 billion and sales outside of the United States at $1.251 billion. For these reasons, Complainant believes that it is reasonable to infer that the CIALIS trademark is well-known throughout the world. Because the Respondents registered the Domain Names between 2012 and 2015, Complainant's rights in the CIALIS trademark predate Respondents� registration dates, and Complainant has both senior and exclusive rights in the CIALIS mark. �Complainant also has an Internet presence, primarily through the website accessed by the domain name , that it uses to advertise and provide information regarding its pharmaceutical product.�� The domain name was registered by Complainant's predecessor-in-interest on August 10, 1999.� Complainant has used this domain name to identify a website since at least as early as June, 2001. Complainant submits and prior Panels cialis over the counter uk have agreed that the CIALIS mark is an invented word that has a high degree of individuality, inherent distinctiveness and no common colloquial use.� See Lilly ICOS LLC v.

Comparison Table

Clarkepharma Co., D2007-0447 (WIPO, May 25, 2007).� An invented word which has acquired a high degree of distinctiveness is deemed to be a highly distinctive mark. See Telstra Corporation Limited v. Telsra/Telecomunicaciones Serafin Rodriguez y Asociados, D2003-0247 (WIPO, July 21, 2003) (determined that since the mark TELSTRA is an invented word and given its nature, widespread advertisement and exposure to consumers worldwide, the mark is highly distinctive).� A domain name which differs very slightly from a trademark has a greater tendency to be confusingly similar where that trademark is highly distinctive.� See Credit Suisse Group v. VPDD UBGM ltd, D2007-0867 (WIPO, September 10, 2007).� �� (3)��� The Domain Names are confusingly similar to the CIALIS mark. The Domain Names are confusing similar to Complainant�s CIALIS mark.� The addition of generic or descriptive words such as "buy," "cheap," and "generic," to Complainant's highly distinctive CIALIS trademark does not prevent a finding of confusing similarity.� Prior Forum Panels have noted that, "the mere addition of a generic or descriptive abbreviation to a registered mark does not negate the confusing similarity of respondent's domain name.

Special Precautions

"� Lilly ICOS LLC v. Joe Pestrak, FA 0504000464558 (NAF, May 31, 2005).� As a result, the addition of generic or descriptive words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark.� See Lilly ICOS LLC v. Andrew Riegel, FA0609000788279 (NAF, October 18, 2006) (finding the addition of the generic term "buy" to Complainant's CIALIS mark did not overcome the confusing similarity between the disputed domain name and the CIALIS mark); Lilly ICOS LLC v. Jay Kim, D2004-0891 (WIPO, January 28, 2005) (finding the addition of the generic word "generic" and the generic letter "a" to Complainant's CIALIS mark did not prevent the domain name from being confusingly similar to the CIALIS mark); and Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (determining that the addition of the words "drug", "online", "buying" and "guide" to Complainant's registered CIALIS trademark did not eliminate the confusing similarity between the CIALIS mark and the domain name because the additional words did not distinguish the owner of the disputed name from Complainant).� In the present case, Respondents have merely added generic and/or descriptive words and phrases to the CIALIS mark in the Domain Names.� Respondents� addition of these words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark.